ClinicalTrials.gg
Sign In
Drug

Albumin-Bound Paclitaxel clinical trials

Also written Abraxane and ABI-007.

A product of Paclitaxel; its studies count on that page too.

studies test it
529
open now
128
in phase 3
47
first study started
2000

How each study uses Albumin-Bound Paclitaxel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Albumin-Bound Paclitaxel studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
7 Jan 2005 · ABRAXANE · NDA 021660 (FDA, Drugs@FDA)
European Union
11 Jan 2008 · Abraxane · EMEA/H/C/000778 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Nab-paclitaxel
214
Nab paclitaxel
53
Albumin-bound paclitaxel
44
paclitaxel albumin-stabilized nanoparticle formulation
41
nanoparticle albumin-bound paclitaxel
28

Brand

Abraxane
210

Development codes

ABI-007
68
RO0247506
1

In one entry with another drug

Given together, or one or the other

Nab-paclitaxel and S-1
4
Nab paclitaxel / gemcitabine
3
Nab-paclitaxel and Gemcitabine
3
GnP
3
surufatinib + gemcitabine + nab-paclitaxel
2
Nab-paclitaxel + Gemcitabine
2
Gemcitabine and Abraxane
2
Nab-paclitaxel + Cisplatin
2

Studies by the year they started

528 studies that test it; most in 2019 (41); 1 more planned to start later

Studies that test Albumin-Bound Paclitaxel, by start year
YearStudies
20001
20012
20033
20043
200511
200618
200718
200826
200910
201010
201112
201221
201325
201436
201535
201621
201725
201820
201941
202030
202129
202230
202324
202424
202526
202627

By phase

A phase 1/2 study counts in both.

Early Phase 1
6
Phase 1
132
Phase 2
388
Phase 3
47
Phase 4
10
No phase
14

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Pancreatic Neoplasms
95
Breast Neoplasms
84
Carcinoma, Non-Small-Cell Lung
36
Triple Negative Breast Neoplasms
20
Squamous Cell Carcinoma of Head and Neck
17
Melanoma
13
Stomach Neoplasms
11
Ovarian Neoplasms
10
Neoplasms
8
Head and Neck Neoplasms
8
Esophageal Squamous Cell Carcinoma
8
Nasopharyngeal Carcinoma
6

Who runs them

Industry 85 · Other 444

Celgene (28) · Fudan University (26) · Sun Yat-sen University (11) · M.D. Anderson Cancer Center (11) · City of Hope Medical Center (9) · Tianjin Medical University Cancer Institute and Hospital (9) · UNC Lineberger Comprehensive Cancer Center (8) · Chinese PLA General Hospital (8)

Often tested with

Tested in the same studies.

Gemcitabine (159) · Carboplatin (73) · Cisplatin (57) · Bevacizumab (31) · Tegafur (19) · Trastuzumab (18) · Cyclophosphamide (18) · Gimeracil (18)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 28 phase 3 studies under way

Albumin-Bound Paclitaxel is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 36, 1 in phase 3

Studies that test Albumin-Bound Paclitaxel, phase 3 first.

Studies

Open first, then newest update. How each study uses Albumin-Bound Paclitaxel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 529

See all 529 studies that test Albumin-Bound Paclitaxel →

Given beside what is tested · 595 — Albumin-Bound Paclitaxel is usual care or a partner of the new treatment

Showing 20 of 595.

As the comparator · 56 — what is tested is compared with Albumin-Bound Paclitaxel

Showing 20 of 56.